Fanale, Michelle

Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma. [electronic resource] - British journal of haematology Jan 2014 - 258-65 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1365-2141

10.1111/bjh.12630 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--pharmacology
Antineoplastic Agents--pharmacology
CD40 Antigens--antagonists & inhibitors
Female
Hodgkin Disease--drug therapy
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Neoplasm Staging
Treatment Outcome
Young Adult